Tags » Brilinta

AstraZeneca's Brilianta tablets efficient in prevention of major vascular events

AstraZeneca on Wednesday announced the results of the SOCRATES trial, assessing the efficacy of Brilinta/Brilique (ticagrelor) 90 mg tablets twice daily, when compared to aspirin 100mg once daily in patients with acute ischaemic stroke or transient ischaemic attack (TIA). 233 more words

News

Antidepressant Brintellix vs Anti-blood Clotting Medication Brilinta

The U.S. Food and Drug Administration is warning health care professionals and patients that reports of confusion between the antidepressant Brintellix and anti-blood clotting medication Brilinta have resulted in the wrong medication being prescribed or dispensed. 155 more words

Knowledge Areas

FDA Warns About Mixups Between Drugs With Similar Names

Here’s a scary thought: dangerous medication mixups could begin at your doctor’s office. The FDA put out a warning today that they’ve received reports of mixups between similarly-named drugs that do very different things. 253 more words

Fda